Prostatic urethral lift: Does size matter?

Journal of Endourology

Volumn 32, Issue 7, 2018, Pages 635-638

  Shah, Bhavik B ^a   Tayon, Kevin ^b   Madiraju, Srigita ^b   Carrion, Rafael E ^a   Perito, Paul ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

^c Perito Urology   (United States)

Author keywords

benign prostatic hypertrophy; ejaculatory function; large prostate; prostatic lift; retention; Urolift

Indexed keywords

AGE; AGED; AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX; ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; ENDOSCOPIC SURGERY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE SIZE; PROSTATIC URETHRAL LIFT; SURGICAL TECHNIQUE; TREATMENT RESPONSE; COMPLICATION; ENDOSCOPY; MIDDLE AGED; PROCEDURES; PROSTATISM; PROSTHESES AND ORTHOSES; QUALITY OF LIFE; TREATMENT OUTCOME; URETHRA;

AGED; ENDOSCOPY; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATISM; PROSTHESES AND IMPLANTS; QUALITY OF LIFE; TREATMENT OUTCOME; URETHRA;

EID: 85049879646     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2017.0855     Document Type: Article

References (15)

1. Maserejian NN, Chen S, Chiu GR, et al. Incidence of lower urinary tract symptoms in a population-based study of men and women. Urology 2013;82:560-564.
2. Litman HJ, McKinlay JB. The future magnitude of urological symptoms in the USA: Projections using the Boston Area Community Health survey. BJU Int 2007;100:820-825.
3. McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 2011;185:1793-1803.
4. Verhamme KM, Dieleman JP, Bleumink GS, Bosch JL, Stricker BH, Sturkenboom MC. Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: The Triumph project. Eur Urol 2003;44:539-545.
5. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003;170:530-547.
6. Kaplan SA. AUA guidelines and their impact on the management of BPH: An update. Rev Urol 2004;6:S46-S52.
7. Sonksen J, Barber NJ, Speakman MJ, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol 2015;68:643-652.
8. Gratzke C, Barber N, Speakman MJ, et al. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int 2016;119:767-775.
9. Roehrborn CG, Gange SN, Shore ND, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: The L.I.F.T. Study. JUrol 2013;190:2161-2167.
10. New Medical Device Treats Urinary Symptoms Related to Enlarged Prostate: U.S. Food & Drug Administration: FDA Press Release, 2013.
11. Roehrborn CG, Rukstalis DB, Barkin J, et al. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol 2015;22:7772-7782.
12. Roehrborn CG. Prostatic urethral lift: A unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Clin North Am 2016;43:357-369.
13. Woo HH, Chin PT, McNicholas TA, et al. Safety and feasibility of the prostatic urethral lift: A novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int 2011;108:82-88.
14. Chin PT, Bolton DM, Jack G, et al. Prostatic urethral lift: Two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 2012;79:5-11.
15. McNicholas TA, Woo HH, Chin PT, et al. Minimally invasive prostatic urethral lift: Surgical technique and multinational experience. Eur Urol 2013;64:292-299.